Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053058
Filing Date
2020-11-10
Accepted
2020-11-10 17:29:15
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20200930.htm 10-Q 1769349
2 EX-10.6 apvo-ex106_127.htm EX-10.6 1081406
3 EX-31.1 apvo-ex311_9.htm EX-31.1 19164
4 EX-31.2 apvo-ex312_6.htm EX-31.2 19422
5 EX-32.1 apvo-ex321_8.htm EX-32.1 10291
6 EX-32.2 apvo-ex322_10.htm EX-32.2 10400
7 GRAPHIC gxpbrlp0dn20000001.jpg GRAPHIC 3344
  Complete submission text file 0001564590-20-053058.txt   7176924

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT apvo-20200930.xml EX-101.INS 1127693
9 XBRL TAXONOMY EXTENSION SCHEMA apvo-20200930.xsd EX-101.SCH 55370
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20200930_cal.xml EX-101.CAL 51202
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20200930_def.xml EX-101.DEF 154216
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20200930_lab.xml EX-101.LAB 404667
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20200930_pre.xml EX-101.PRE 303347
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 201302299
SIC: 2834 Pharmaceutical Preparations